Progesteron receptor status in determining the prognosis of estrogen receptor positive / HER2-negative breast carcinoma | ...
Myeloproliferative Neoplasms *Head and Neck Cancers *Lung and other Thoracic Tumours *Small-Cell Lung Cancer ... Breast Cancer. Access all ESMO scientific and educational resources on this topic. ... 279P - Progesteron receptor status in determining the prognosis of estrogen receptor positive / HER2-negative breast carcinoma ... Progesteron receptor status in determining the prognosis of estrogen receptor positive / HER2-negative breast carcinoma ...http://oncologypro.esmo.org/Topics/Pathology-Molecular-Biology/Progesteron-receptor-status-in-determining-the-prognosis-of-estrogen-receptor-positive-HER2-negative-breast-carcinoma
Predictors of Ovarian Insufficiency in Young Breast Cancer Patients - Full Text View - ClinicalTrials.gov
Breast cancer. Ovarian insufficiency. Ovarian failure. Reproduction. Additional relevant MeSH terms: Breast Neoplasms. ... Ovarian function after breast cancer diagnosis has implications on breast cancer prognosis, choice of adjuvant therapy and ... Predictors of Ovarian Insufficiency in Young Breast Cancer Patients (POISE). The safety and scientific validity of this study ... The investigators plan to follow a group of young women from breast cancer diagnosis to five years after chemotherapy. The ...https://clinicaltrials.gov/ct2/show/NCT01197456?recr=Open&cond=%22Ovarian+Failure%2C+Premature%22&rank=19
No Increase in Breast Cancer Recurrence with Concurrent Use of Tamoxifen and Some CYP2D6-Inhibiting Medications | Cancer...
breast neoplasms. *tamoxifen, pharmacology and therapeutic use. *tamoxifen, antagonists and inhibitors. *cytochrome P-450 2D6 ... Using the Danish Breast Cancer Cooperative Group Registry, we identified 366 cases with local or distant breast cancer ... No Increase in Breast Cancer Recurrence with Concurrent Use of Tamoxifen and Some CYP2D6-Inhibiting Medications. Thomas P. ... We computed the breast cancer recurrence odds ratio (OR) and 95% confidence interval for each medication. The pooled recurrence ...http://cebp.aacrjournals.org/content/early/2009/08/14/1055-9965.EPI-09-0516
Breast neoplasms | Radiology Reference Article | Radiopaedia.org
intra-lobular (epithelial and stromal) inter-lobular breast lymphoma metastasis to breast Intralobular an... ... There are many types of breast neoplasms, which can be divided into the following broad oversimplified categories as a starting ... breast pathology *malignant lesions* breast cancer *breast adenocacrinoma *ductal breast carcinoma * ductal carcinoma in situ ( ... Breast within a breast sign' in hamartoma'Breast within a breast sign' in hamartoma ...https://radiopaedia.org/articles/breast-neoplasms
I Have Male Breast Neoplasms
Male Breast Neoplasms anonymous support group with inform... ... people sharing true stories in the I Have Male Breast Neoplasms ... Do You Have Male Breast Neoplasms? Join friendly ... I Have Male Breast Neoplasms does not have any stories yet. Be ... Male Breast Neoplasms anonymous support group with information on diagnosis, treatment, symptoms, along with personal stories ... and experiences with Male Breast Neoplasms. You're not alone. Report Group. ...http://www.experienceproject.com/groups/Have-Male-Breast-Neoplasms/98618
Search of: Recruiting, Not yet recruiting, Available Studies | 'Inflammatory Breast Neoplasms' - Modify Search - ClinicalTrials...
Search of: Recruiting, Not yet recruiting, Available Studies , 'Inflammatory Breast Neoplasms' - Modify Search. Fill in any or ...https://clinicaltrials.gov/ct2/results/refine?recr=Open&cond=%22Inflammatory+Breast+Neoplasms%22
Search of: Recruiting, Not yet recruiting, Available Studies | 'Breast Neoplasms' AND 'Breast Diseases' - List Results -...
Study of Hypofractionated Partial Breast Irradiation in Women With Early Stage Breast Cancer. *Malignant Neoplasm of Breast ... Comparison of the Breast Tumor Microenvironment. *Triple Negative Breast Cancer. *Hormone Receptor Positive Malignant Neoplasm ... Window of Opportunity Trial of Dasatinib in Operable Triple Negative Breast Cancers With nEGFR. *Breast Neoplasms ... Phase 1 Study of DS-8201a in HER-2 Breast Cancer Patients. *Malignant Neoplasm of Breast ...https://clinicaltrials.gov/ct2/results?recr=open&cond=%22Breast+Neoplasms%22+AND+%22Breast+Diseases%22&show_down=Y
Intestinal obstruction due to malign breast neoplasm and peritoneal carcinomatosis: a case report
Keywords : intestinal obstruction; secondary; breast neoplasms; carcinoma; abdomen; acute. · abstract in Portuguese · text in ... Intestinal obstruction due to malign breast neoplasm and peritoneal carcinomatosis: a case report. J. Coloproctol. (Rio J.) [ ... A case of colonic obstruction due to carcinomatosis secondary to breast cancer is reported, emphasizing its diagnostic aspects ... Peritoneal carcinomatosis due to breast cancer is rare and gastrointestinal tract involvement is also unusual. Symptoms are ...http://www.scielo.br/scielo.php?script=sci_abstract&pid=S2237-93632012000200016&lng=en&nrm=iso&tlng=en
Prevalence of risk factors for breast neoplasm in the city of Maringá, Paraná state, Brazil
... 1 ... As for the family history of breast cancer, 2.3% (10) of the women reported that their mother has or had breast cancer. When ... This risk increases when the relative has breast cancer before the age of 50 years and in both breasts(15). ... with breast cancer(3). In both studies, a small number of women had some first-degree relatives with breast cancer, like in the ...http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0104-11692010000300009&lng=en&nrm=iso
Trastuzumab Active Not Recruiting Phase 0 Trials for Neoplasms, Breast Diagnostic - DrugBank
Trastuzumab Active Not Recruiting Phase 0 Trials for Neoplasms, Breast Diagnostic. Back to Trastuzumab ... Defining the HER2 Positive (+) Breast Cancer Kinome Response to Trastuzumab, Pertuzumab, Combination Trastuzumab +Pertuzumab, ...https://www.drugbank.ca/drugs/DB00072/clinical_trials?conditions=DBCOND0030201&phase=0&purpose=diagnostic&status=active_not_recruiting
ICD-9 Diagnosis Code 239.3 Breast neoplasm NOS
Short Description: Breast neoplasm NOS Long Description: Neoplasm of unspecified nature of breast This is the 2014 version of ... Neoplasms (140-239) * Neoplasms of unspecified nature (239) *239 Neoplasm of unspecified nature ... It is not necessary to follow the "see also" note when the original main term provides the necessary code. Neoplasm, breast ... T1b: Breast tumor >0.5 cm but <= 1 cm in greatest dimension *T1c: >1 cm but <= 2 cm in greatest dimension: BREAST: Complete ...https://icdlist.com/icd-9/239.3
SE Asia Offers the Latest Treatments for Breast Neoplasm
... A neoplasm of the breast is a tumour that forms on the breast; it can ... But thanks to the prevalence of medical tourism, patients with breast neoplasms can now undergo cancer treatment in Southeast ... Surgery remains to be the first line of treatment for most breast tumours. However, although it has a high success rating, many ...https://www.docdoc.com/medical-travel/se-asia-offers-the-latest-treatments-for-breast-neoplasm
2018 ICD-10-CM Diagnosis Code C50.9: Malignant neoplasm of breast of unspecified site
C50.829 Malignant neoplasm of overlapping sites of unspecified male breast C50.9 Malignant neoplasm of breast of unspecified ... C50.919 Malignant neoplasm of unspecified site of unspecified female breast C50.92 Malignant neoplasm of breast of unspecified ... C50.921 Malignant neoplasm of unspecified site of right male breast C50.922 Malignant neoplasm of unspecified site of left male ... C50.811 Malignant neoplasm of overlapping sites of right female breast C50.812 Malignant neoplasm of overlapping sites of left ...http://www.icd10data.com/ICD10CM/Codes/C00-D49/C50-C50/C50-/C50.9
Breast cancer and other second neoplasms after childhood Hodgkin's disease
... Bhatia S, Robison LL, Oberlin O, et al.. Abstract: ... Systematic screening for breast cancer could be important in the health care of such women.. This is a service of:. Rheinische ... The risk of solid tumors, especially breast cancer, is high among women who were treated with radiation for childhood Hodgkin's ... Patients who survive Hodgkin's disease are at increased risk for second neoplasms. As survival times increase, solid tumors are ...http://www.meb.uni-bonn.de/cgi-bin/mycite?ExtRef=MEDL/96172864/PMID/8592547
Malignant neoplasm of breast
Build: Sat Feb 17 08:59:16 EST 2018 (commit: 16064c5). National Center for Advancing Translational Sciences (NCATS), 6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-435-0888. ...https://pharos.nih.gov/idg/diseases/Malignant%20neoplasm%20of%20breast
Items where Subject is "WP Gynecology | WP 800-910 Breast | WP 840-870 Breast Diseases. Neoplasms" - Repozitorij Medicinskog...
Items where Subject is "WP Gynecology , WP 800-910 Breast , WP 840-870 Breast Diseases. Neoplasms" Up a level. ... Breast cancer risk factors among women aged 50-69 in population-based screening program in Croatia]. PhD thesis, Sveučilište u ... The correlation of peritumoral clefts with myofibroblastic stromal reaction and lymph vessel density in invasive ductal breast ... WP 800-910 Breast (5)*WP 840-870 Breast Diseases. Neoplasms (5) ...http://medlib.mef.hr/view/subjects/WP840.html
Internet Archive Search: subject:"mastectomy"
Topics: Breast, Mastectomy, Breast Neoplasms, Breast Neoplasms, History, 20th Century, Mastectomy, Sein,.... ... Learn How To Get a Correct Breast Cancer Diagnosis; The Best Treatment; and What are the Best Breast Cancer Screening Methods. ... Michael Lagios an nationally recognized breast pathologist and medical director of The Breast Cancer Consultation Service. The ... Topics: Hospital utilization, Health insurance, Breast, Breast, Mastectomy, Lymph nodes, Medical.... Source: special. ...http://archive.org/search.php?query=subject%3A%22mastectomy%22
Compound Report Card
BREAST NEOPLASMS. D001943. EFO:0000305. BREAST CARCINOMA. 2. ClinicalTrials. ClinicalTrials. NEOPLASMS. D009369. EFO:0000311. ... MOUTH NEOPLASMS. D009062. EFO:0003868. MOUTH NEOPLASM. 3. ClinicalTrials. SKIN NEOPLASMS. D012878. EFO:0004198. SKIN NEOPLASM. ... NEOPLASMS. D009369. EFO:0000616. NEOPLASM. 4. ATC. ClinicalTrials. ESOPHAGEAL NEOPLASMS. D004938. EFO:0002916. ESOPHAGEAL ... BRAIN NEOPLASMS. D001932. EFO:0003833. BRAIN NEOPLASM. 2. ClinicalTrials. CARCINOMA, RENAL CELL. D002292. EFO:0000681. RENAL ...https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL553
Recent trends in breast cancer incidence and mortality - Lacey - 2002 - Environmental and Molecular Mutagenesis - Wiley Online...
Association analysis of ERCC5 gene polymorphisms with risk of breast cancer in Han women of northwest China, Breast Cancer, ... Recent trends in breast cancer incidence and mortality †. Authors. *. James V. Lacey Jr.,. Corresponding author*E-mail address ... Change of mammographic density predicts the risk of contralateral breast cancer - a case-control study, Breast Cancer Research ... Breast cancer accounts for one-third of cancer diagnoses and 15% of cancer deaths in U.S. women. Its 192,000 cases and 40,000 ...http://onlinelibrary.wiley.com/doi/10.1002/em.10062/abstract
Compound Report Card
BREAST NEOPLASMS. D001943. EFO:0000305. BREAST CARCINOMA. 2. ClinicalTrials. CHORIORETINITIS. D002825. 4. ... NEOPLASMS. D009369. EFO:0000616. NEOPLASM. 4. ClinicalTrials. OPHTHALMIA, SYMPATHETIC. D009879. EFO:1001205. SYMPATHETIC ... NEOPLASMS. D009369. EFO:0000311. CANCER. 4. ClinicalTrials. NERVOUS SYSTEM DISEASES. D009422. EFO:0000618. NERVOUS SYSTEM ... PROSTATIC NEOPLASMS. D011471. EFO:0001663. PROSTATE CARCINOMA. 2. ClinicalTrials. PSORIASIS. D011565. EFO:0000676. PSORIASIS. 4 ...https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL384467
Breast cancer - SNPedia
Breast cancer. From SNPedia. (Redirected from Breast Neoplasms). Jump to:navigation, search ... The Genes-to-Systems Breast Cancer Database lists breast cancer genes correlated with the cell cycle process. ... PMID 16768547] Breast Cancer Our findings suggest that BARD1 Cys557Ser is an ancient variant that confers risk of single and ... As for the good news, some SNPs are associated with lower risk for breast cancer; these include: * rs3218536 in the DNA repair ...https://snpedia.com/index.php/Breast_Neoplasms
Standard Versus Continuous Capecitabine in Advanced Breast Cancer - Full Text View - ClinicalTrials.gov
Breast Neoplasms. Neoplasms by Site. Neoplasms. Breast Diseases. Skin Diseases. Capecitabine. Antimetabolites, Antineoplastic. ... Standard Versus Continuous Capecitabine in Advanced Breast Cancer. The safety and scientific validity of this study is the ... Capecitabine is active in metastatic breast cancer but the conventional schedule (1250 mg/m2/12 hr 2 weeks on, one week off) ... Capecitabine is active in metastatic breast cancer but the conventional schedule (1250 mg/m2/12 hr 2 weeks on, one week off) ...https://clinicaltrials.gov/show/NCT00418028
Randomized Phase III Study Of Exemestane (Aromasin) For 5 Years Versus Tamoxifen for 2.5 to 3 Years Followed By Exemestane -...
Breast Neoplasms. Interventions: Drug: exemestane (Aromasin). Drug: tamoxifen + exemestane. Participant Flow Hide Participant ... Number of Participants With New Primary Non-breast Cancers [ Time Frame: Baseline (Month 0) up to 5 years ]. ... Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial. Lancet. 2011 Jan 22;377(9762):321- ... Time to New Primary Breast Cancers [ Time Frame: Baseline (Month 0) up to 5 years ]. ...https://clinicaltrials.gov/ct2/show/results/NCT00036270?show_locs=Y
The BEACON Study (Breast Cancer Outcomes With NKTR-102) - Full Text View - ClinicalTrials.gov
Locally Recurrent Breast Cancer Metastatic Breast Cancer Drug: NKTR-102 Drug: Treatment of Physician's Choice (TPC) Phase 3 ... Breast Cancer Res Treat. 2017 Sep;165(2):329-341. doi: 10.1007/s10549-017-4304-7. Epub 2017 Jun 13. Erratum in: Breast Cancer ... Breast Neoplasms. Neoplasms by Site. Neoplasms. Breast Diseases. Skin Diseases. To Top ... The BEACON Study (Breast Cancer Outcomes With NKTR-102): A Phase 3 Open-Label, Randomized, Multicenter Study of NKTR-102 Versus ...https://clinicaltrials.gov/ct2/show/study/NCT01492101?term=breast+cancer+young+women&lup_s=01%2F07%2F2013&lup_d=30&show_locs=Y
An Open-Label Multicenter Phase 2 Window of Opportunity Study Evaluating Ganetespib in Women With Breast Cancer - Full Text...
Breast Neoplasms. Triple Negative Breast Neoplasms. Neoplasms by Site. Neoplasms. Breast Diseases. Skin Diseases. ... Breast Cancer HER-2 Positive Breast Cancer Triple Negative Breast Cancer ER/Progressive Response (PR) + Refractory to Prior ... An Open-Label Multicenter Phase 2 Window of Opportunity Study Evaluating Ganetespib in Women With Breast Cancer (Enchant). The ... Experimental: Triple negative breast cancer Closed to enrollment. Drug: ganetespib Ganetespib 150 mg/m2 will be administered ...https://clinicaltrials.gov/ct2/show/NCT01677455?recr=Open&cond=%22Triplets%22&rank=14
Download our free solidary book to support research on VHL disease